Hidde H. Huidekoper

1.3k total citations
44 papers, 651 citations indexed

About

Hidde H. Huidekoper is a scholar working on Clinical Biochemistry, Molecular Biology and Rheumatology. According to data from OpenAlex, Hidde H. Huidekoper has authored 44 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Clinical Biochemistry, 16 papers in Molecular Biology and 16 papers in Rheumatology. Recurrent topics in Hidde H. Huidekoper's work include Metabolism and Genetic Disorders (22 papers), Glycogen Storage Diseases and Myoclonus (9 papers) and Lysosomal Storage Disorders Research (9 papers). Hidde H. Huidekoper is often cited by papers focused on Metabolism and Genetic Disorders (22 papers), Glycogen Storage Diseases and Myoclonus (9 papers) and Lysosomal Storage Disorders Research (9 papers). Hidde H. Huidekoper collaborates with scholars based in Netherlands, United States and United Kingdom. Hidde H. Huidekoper's co-authors include Frédéric M. Vaz, Aad Verrips, Frits A. Wijburg, Albert H. Bootsma, Mariëtte T. Ackermans, Ronald J. A. Wanders, Coen C. Paulusma, Annet M. Bosch, Ron A. Wevers and Hans P. Sauerwein and has published in prestigious journals such as Hepatology, Neurology and Journal of Lipid Research.

In The Last Decade

Hidde H. Huidekoper

42 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hidde H. Huidekoper Netherlands	15	214	208	191	187	127	44	651
Khaja Basheeruddin United States	15	177 0.8×	239 1.1×	37 0.2×	43 0.2×	234 1.8×	25	605
Arno van Rooij Netherlands	12	62 0.3×	398 1.9×	67 0.4×	207 1.1×	49 0.4×	16	630
Nico J. Ponne Netherlands	10	128 0.6×	308 1.5×	453 2.4×	61 0.3×	76 0.6×	11	782
Chizuru Watanabe Japan	12	144 0.7×	196 0.9×	126 0.7×	68 0.4×	34 0.3×	19	594
Jean-Marie Saudubray France	14	210 1.0×	383 1.8×	42 0.2×	397 2.1×	133 1.0×	15	952
Mary Anne Preece United Kingdom	11	56 0.3×	162 0.8×	33 0.2×	166 0.9×	75 0.6×	20	377
Dmitri Svistounov Norway	12	77 0.4×	187 0.9×	52 0.3×	57 0.3×	111 0.9×	19	632
Nike Müller Germany	11	118 0.6×	209 1.0×	46 0.2×	25 0.1×	132 1.0×	15	571
Javier Casado Spain	14	87 0.4×	149 0.7×	153 0.8×	82 0.4×	95 0.7×	32	574
Péter Reismann Hungary	13	136 0.6×	215 1.0×	26 0.1×	152 0.8×	142 1.1×	44	654

Countries citing papers authored by Hidde H. Huidekoper

Since Specialization

Citations

This map shows the geographic impact of Hidde H. Huidekoper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidde H. Huidekoper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidde H. Huidekoper more than expected).

Fields of papers citing papers by Hidde H. Huidekoper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidde H. Huidekoper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidde H. Huidekoper. The network helps show where Hidde H. Huidekoper may publish in the future.

Co-authorship network of co-authors of Hidde H. Huidekoper

This figure shows the co-authorship network connecting the top 25 collaborators of Hidde H. Huidekoper. A scholar is included among the top collaborators of Hidde H. Huidekoper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidde H. Huidekoper. Hidde H. Huidekoper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Häberle, Johannes, et al.. (2024). Mapping challenges in the accessibility of treatment products for urea cycle disorders: A survey of European healthcare professionals. Journal of Inherited Metabolic Disease. 48(1). e12815–e12815.

Wagenmakers, Margreet A. E. M., et al.. (2024). Quality of life in children with erythropoietic protoporphyria: a case–control study. The Journal of Dermatology. 51(8). 1068–1078. 4 indexed citations

Smith, Desirée E.C., Hidde H. Huidekoper, Mirjam M. C. Wamelink, et al.. (2024). 5,10‐methenyltetrahydrofolate synthetase deficiency: An extreme rare defect of folate metabolism in two Dutch siblings. JIMD Reports. 65(2). 49–55. 1 indexed citations

Beek, Nadine A. M. E. van der, et al.. (2023). Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review. Biomolecules. 13(9). 1414–1414. 2 indexed citations

Beek, Nadine A. M. E. van der, Esther Brusse, Michelle E. Kruijshaar, et al.. (2023). Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions. BioDrugs. 37(5). 685–698. 5 indexed citations

Ferdinandusse, Sacha, Saskia N. van der Crabben, Eugènie Dekkers, et al.. (2023). Newborn screening for primary carnitine deficiency: who will benefit? – a retrospective cohort study. Journal of Medical Genetics. 60(12). 1177–1185. 7 indexed citations

Beek, Nadine A. M. E. van der, et al.. (2023). Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study. Orphanet Journal of Rare Diseases. 18(1). 108–108. 9 indexed citations

Kuijpers, Taco W., Andrica C. H. de Vries, Ester M. van Leeuwen, et al.. (2022). Megalobastic anemia, infantile leukemia, and immunodeficiency caused by a novel homozygous mutation in the DHFR gene. Blood Advances. 6(22). 5829–5834. 2 indexed citations

Vaz, Frédéric M., Rob Barto, Michael H. Gelb, et al.. (2022). Newborn screening for Cerebrotendinous Xanthomatosis: A retrospective biomarker study using both flow-injection and UPLC-MS/MS analysis in 20,000 newborns. Clinica Chimica Acta. 539. 170–174. 7 indexed citations

10.

Huidekoper, Hidde H., Michelle E. Kruijshaar, Dimitris Rizopoulos, et al.. (2022). Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: A multicentre observational follow-up study of the European Pompe Consortium. Molecular Genetics and Metabolism. 135(2). S39–S39. 1 indexed citations

11.

Hong, Xinying, Martin Sadı́lek, Andrea E. DeBarber, et al.. (2020). Toward newborn screening of cerebrotendinous xanthomatosis: results of a biomarker research study using 32,000 newborn dried blood spots. Genetics in Medicine. 22(10). 1606–1612. 21 indexed citations

12.

Ferdinandusse, Sacha, Gert J. Geurtsen, Carla E. M. Hollak, et al.. (2020). Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers. Brain Communications. 2(1). fcaa006–fcaa006. 27 indexed citations

13.

Harlaar, Laurike, Nadine A. M. E. van der Beek, Pieter A. van Doorn, et al.. (2019). Discontinuation of enzyme replacement therapy in adults with Pompe disease: Evaluating the European POmpe Consortium stop criteria. Neuromuscular Disorders. 30(1). 59–66. 9 indexed citations

14.

Schene, Imre F., Christoph Korenke, Hidde H. Huidekoper, et al.. (2018). Glycogen Storage Disease Type IV: A Rare Cause for Neuromuscular Disorders or Often Missed?. JIMD Reports. 45. 99–104. 8 indexed citations

15.

Vaz, Frédéric M., Albert H. Bootsma, Willem Kulik, et al.. (2017). A newborn screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios. Journal of Lipid Research. 58(5). 1002–1007. 23 indexed citations

16.

Vaz, Frédéric M., Hidde H. Huidekoper, & Coen C. Paulusma. (2017). Extended Abstract: Deficiency of Sodium Taurocholate Cotransporting Polypeptide (SLC10A1): A New Inborn Error of Metabolism with an Attenuated Phenotype. Digestive Diseases. 35(3). 259–260. 9 indexed citations

17.

Huidekoper, Hidde H., et al.. (2016). Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: An available high-throughput liquid-chromatography tandem mass spectrometry method. Molecular Genetics and Metabolism Reports. 7. 11–15. 15 indexed citations

18.

Vrisekoop, Nienke, Julia Drylewicz, Rogier van Gent, et al.. (2015). Quantification of naive and memory T-cell turnover during HIV-1 infection. AIDS. 29(16). 2071–2080. 22 indexed citations

19.

Soeters, Maarten R., Hidde H. Huidekoper, Marinus Durán, et al.. (2010). Extended metabolic evaluation of suspected symptomatic hypoglycemia: the prolonged fast and beyond. Metabolism. 59(11). 1543–1550. 1 indexed citations

20.

Huidekoper, Hidde H., et al.. (2006). Prolonged moderate‐intensity exercise without and with L‐carnitine supplementation in patients with MCAD deficiency. Journal of Inherited Metabolic Disease. 29(5). 631–636. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact